Ophthalmic Viscoelastic Devices Market Size

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 10.5 billion in 2023 and is poised to grow from USD 11.72 billion in 2024 to USD 28.19 billion by 2032, growing at a CAGR of 11.6% during the forecast period (2025-2032).

Increasing demand for minimally invasive eye surgeries and advancements in viscoelastic material formulations are further propelling market expansion. Several eye-related diseases, including cataract, glaucoma, corneal transplant, age-related macular degeneration, and diabetic retinopathy, require the use of ophthalmic viscoelastic devices during surgery. These ophthalmic visco-surgical devices are critical for providing proper treatment to patients in order to avoid further vision damage or loss of vision.

The ophthalmic viscoelastic devices market is witnessing steady growth driven by the rising prevalence of eye disorders such as cataracts, glaucoma, and age-related macular degeneration.

The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. In line with this, improving access to ophthalmic care facilities and rising awareness about ocular disorders are acting as another growth-inducing factor. Moreover, the widespread utilization of viscoadaptive ophthalmic viscosurgical devices, due to the increasing number of complex ocular surgical cases and its biphasic benefit of eliminating the need for two syringes is propelling the market growth. In corneal transplantation surgery (keratoplasty), the damaged cornea is replaced by donated corneal tissue.

How Is AI Transforming the Ophthalmic Viscoelastic Devices Market?

Artificial intelligence (AI) affects the ophthalmic viscoelastic devices market by increasing surgical accuracy and patient results. AI-operated depiction and diagnostic tools enable ophthalmologists to create better planning and perform complex eye surgery, which allows more accurate use of viscolatic tools. In 2024, for example, a leading medical technology company introduced an AI capable surgical guidance system, which helps surgeons during cataract operations by providing real-time reaction and optimal suggestions for viscolastic unit. This innovation increases surgical accuracy and reduces the time of the process, showing how AI-powered solutions become integrated with eye-related surgery.